JPMorgan Chase & Co’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.29M | Buy |
888,016
+1,311
| +0.1% | +$4.86K | ﹤0.01% | 3004 |
|
|
2025
Q1 | $2.86M | Buy |
886,705
+66,636
| +8% | +$215K | ﹤0.01% | 3032 |
|
|
2024
Q4 | $4.57M | Buy |
820,069
+504,086
| +160% | +$2.81M | ﹤0.01% | 2821 |
|
|
2024
Q3 | $3.42M | Sell |
315,983
-29,790
| -9% | -$322K | ﹤0.01% | 2881 |
|
|
2024
Q2 | $7.26M | Sell |
345,773
-56,768
| -14% | -$1.19M | ﹤0.01% | 2311 |
|
|
2024
Q1 | $12.8M | Sell |
402,541
-25,849
| -6% | -$824K | ﹤0.01% | 1972 |
|
|
2023
Q4 | $8.68M | Sell |
428,390
-157,061
| -27% | -$3.18M | ﹤0.01% | 2211 |
|
|
2023
Q3 | $7.45M | Buy |
585,451
+128,237
| +28% | +$1.63M | ﹤0.01% | 2174 |
|
|
2023
Q2 | $8.26M | Buy |
457,214
+16,901
| +4% | +$305K | ﹤0.01% | 2172 |
|
|
2023
Q1 | $7.57M | Buy |
440,313
+339
| +0.1% | +$5.83K | ﹤0.01% | 2193 |
|
|
2022
Q4 | $9.77M | Sell |
439,974
-13,134
| -3% | -$292K | ﹤0.01% | 1933 |
|
|
2022
Q3 | $3.64M | Sell |
453,108
-25,649
| -5% | -$206K | ﹤0.01% | 2545 |
|
|
2022
Q2 | $3.34M | Buy |
478,757
+111,212
| +30% | +$777K | ﹤0.01% | 2674 |
|
|
2022
Q1 | $5.56M | Buy |
367,545
+84,158
| +30% | +$1.27M | ﹤0.01% | 2494 |
|
|
2021
Q4 | $6.22M | Buy |
283,387
+53,451
| +23% | +$1.17M | ﹤0.01% | 2427 |
|
|
2021
Q3 | $6.2M | Buy |
229,936
+216,850
| +1,657% | +$5.85M | ﹤0.01% | 2439 |
|
|
2021
Q2 | $316K | Sell |
13,086
-7,785
| -37% | -$188K | ﹤0.01% | 4249 |
|
|
2021
Q1 | $905K | Buy |
+20,871
| New | +$905K | ﹤0.01% | 3717 |
|